The invention relates to a medicament for treating a
prostatic disease, which is prepared from the following Chinese medical herbs in parts by weight: 40-60 parts of rehmanniae praeparatum, 40-60 parts of rehmanniae vaporata, 50-70 parts of common macrocarpium fruit, 40-60 parts of
epimedium, 40-60 parts of morindae, 40-60 parts of desertliving
cistanche, 40-60 parts of south dodder seed, 40-60 parts of malaytea scurfpea fruit, 40-60 parts of common
cnidium fruit, 40-60 parts of palmleaf raspberry fruit, 30-50 parts of Chinese magnoliavine fruit, 20-40 parts of
cassia bark, 30-50 parts of fennel fruit, 30-50 parts of cervus nippon temminck, 30-50 parts of
eucommia bark, 30-50 parts of
achyranthes root, 30-50 parts of Indian buead, 30-50 parts of dioscoreae, 30-50 parts of Chinese eaglewood, 40-60 parts of
dendrobium, 40-60 parts of
scrophularia, 30-50 parts of cluster mallow fruit, 40-60 parts of herba pyrrosiae, 40-60 parts of
plantago seed, 40-60 parts of rhizoma anemarrhenae, 40-60 parts of
phellodendron, 40-60 parts of white paeony root and 30-50 parts of raw liquorice root, and capsules are prepared by the steps of
grinding the Chinese medical herbs into
fine powder and encapsuling. The medicament has effects of invigorating yin, supporting yang, resuscitating and treating stranguria and is mainly suitable for chronic
prostatitis or prostatic
hyperplasia.